• Title of article

    The Three P’s: Parotid, PD-L1, and Pembrolizumab

  • Author/Authors

    Kerns, Tamie Tripler Army Medical Cente - Jarrett White Road - DHCK-DM- Honolulu - HI , USA , Wiggins, Amanda Tripler Army Medical Cente - Jarrett White Road - DHCK-DM- Honolulu - HI , USA , Arter, Zhaohui Tripler Army Medical Cente - Jarrett White Road - DHCK-DM- Honolulu - HI , USA

  • Pages
    4
  • From page
    1
  • To page
    4
  • Abstract
    We present a case of recurrent, platinum-refractory undifferentiated carcinoma of the parotid which was treated with checkpointinhibitor, Pembrolizumab, and achieved a complete response to therapy. We review the literature of checkpoint inhibitor use inundifferentiated carcinoma of the parotid.
  • Keywords
    Three P’s , Parotid , PD-L1 , Pembrolizumab , platinum-refractory undifferentiated carcinoma , FNA
  • Journal title
    Case Reports in Oncological Medicine
  • Serial Year
    2019
  • Full Text URL
    downloads.hindawi.com/journals/crionm/2019/2305315.pdf
  • Record number

    2610530

    • Link To Document
    https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=2610530